Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

AUROBINDO PHARMA LTD

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 25
  • 0 comments

FDA approve MYCOPHENOLATE MOFETIL

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 24
  • 0 comments

FDA approve PENCICLOVIR

Comment Full text

SANDOZ

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 20
  • 0 comments

FDA approve AMPICILLIN SODIUM; SULBACTAM SODIUM

Comment Full text

UNIQUE

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 22
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

UNIQUE

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 26
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 25
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 27
  • 0 comments

FDA approve ENZALUTAMIDE

Comment Full text

ZHEJIANG JUTAI PHARM

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 23
  • 0 comments

FDA approve AMANTADINE HYDROCHLORIDE

Comment Full text

INFORLIFE

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 19
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 24
  • 0 comments

FDA approve POMALIDOMIDE

Comment Full text
  • Previous
  • 247
  • 248
  • 249
  • 250
  • 251
  • Next

Search

News categories

  • Technical Exchange News(9973)
  • Event(412)
  • SEC News(168638)
  • FDA Approval(9377)
  • Company Report(721)
  • Business News(112351)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin